T. Rowe Price Associates’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q3
Sell
-67,365
Closed -$1.21M 2659
2020
Q2
$1.21M Sell
67,365
-7,351
-10% -$132K ﹤0.01% 1698
2020
Q1
$533K Buy
74,716
+6,410
+9% +$45.7K ﹤0.01% 1959
2019
Q4
$1.63M Buy
68,306
+15,764
+30% +$376K ﹤0.01% 1680
2019
Q3
$1.41M Sell
52,542
-9,195
-15% -$247K ﹤0.01% 1669
2019
Q2
$1.68M Sell
61,737
-5,222
-8% -$142K ﹤0.01% 1646
2019
Q1
$2.32M Sell
66,959
-8,020
-11% -$278K ﹤0.01% 1541
2018
Q4
$1.46M Buy
74,979
+23,213
+45% +$453K ﹤0.01% 1655
2018
Q3
$1.38M Sell
51,766
-1,214
-2% -$32.3K ﹤0.01% 1738
2018
Q2
$2M Buy
52,980
+2,319
+5% +$87.6K ﹤0.01% 1595
2018
Q1
$1.66M Buy
50,661
+22,311
+79% +$729K ﹤0.01% 1621
2017
Q4
$1.38M Buy
28,350
+1,400
+5% +$68.1K ﹤0.01% 1657
2017
Q3
$1.46M Buy
26,950
+3,710
+16% +$200K ﹤0.01% 1634
2017
Q2
$1.31M Hold
23,240
﹤0.01% 1679
2017
Q1
$911K Sell
23,240
-90
-0.4% -$3.53K ﹤0.01% 1823
2016
Q4
$524K Sell
23,330
-10,600
-31% -$238K ﹤0.01% 2019
2016
Q3
$771K Sell
33,930
-609,289
-95% -$13.8M ﹤0.01% 1842
2016
Q2
$15.2M Buy
643,219
+5,000
+0.8% +$118K ﹤0.01% 1184
2016
Q1
$13M Buy
638,219
+359,090
+129% +$7.33M ﹤0.01% 1208
2015
Q4
$14.4M Sell
279,129
-115,350
-29% -$5.93M ﹤0.01% 1190
2015
Q3
$16.8M Buy
394,479
+3,700
+0.9% +$158K ﹤0.01% 1152
2015
Q2
$17.8M Sell
390,779
-18,300
-4% -$834K ﹤0.01% 1171
2015
Q1
$15.5M Sell
409,079
-20,896
-5% -$793K ﹤0.01% 1201
2014
Q4
$12.2M Sell
429,975
-87,678
-17% -$2.48M ﹤0.01% 1267
2014
Q3
$13.1M Sell
517,653
-49,926
-9% -$1.26M ﹤0.01% 1230
2014
Q2
$16.6M Sell
567,579
-157,956
-22% -$4.61M ﹤0.01% 1169
2014
Q1
$18.8M Buy
725,535
+92,156
+15% +$2.39M ﹤0.01% 1126
2013
Q4
$16.3M Sell
633,379
-112,400
-15% -$2.89M ﹤0.01% 1149
2013
Q3
$19.7M Sell
745,779
-32,000
-4% -$847K ﹤0.01% 1080
2013
Q2
$18.9M Buy
+777,779
New +$18.9M 0.01% 1077